TotalMarketCap

CytomX Therapeutics

CTMXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$467.394 M

$2.15 -8.72%

Close of 6 Nov 2026

As of 6 Nov 2026, CytomX Therapeutics (CTMX) has a market capitalization of $467.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$76.2M

#2579 by revenue

Earnings

-$17.4M

Loss-making

Shares outstanding

218,004,920

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #191Indaptus TherapeuticsINDP$483.8M
  2. #192Crescent BiopharmaCBIO$482.1M
  3. #193CytomX TherapeuticsCTMX$467.4M
  4. #194Aquestive TherapeuticsAQST$458.1M
  5. #195EvolusEOLS$452.4M

What if CytomX Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$129,586.81

Per share 60,413× higher

Bitcoin $1.53T

$7,011.72

Per share 3,269× higher

Apple $5.02T

$23,018.81

Per share 10,731× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for CytomX Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.